GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » Shiller PE Ratio

Tasly Pharmaceutical Group Co (SHSE:600535) Shiller PE Ratio : 17.37 (As of May. 03, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co Shiller PE Ratio?

As of today (2024-05-03), Tasly Pharmaceutical Group Co's current share price is ¥15.46. Tasly Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2024 was ¥0.89. Tasly Pharmaceutical Group Co's Shiller PE Ratio for today is 17.37.

The historical rank and industry rank for Tasly Pharmaceutical Group Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600535' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.11   Med: 29.44   Max: 109.32
Current: 17.5

During the past years, Tasly Pharmaceutical Group Co's highest Shiller PE Ratio was 109.32. The lowest was 10.11. And the median was 29.44.

SHSE:600535's Shiller PE Ratio is ranked better than
69.42% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.95 vs SHSE:600535: 17.50

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Tasly Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.89 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tasly Pharmaceutical Group Co Shiller PE Ratio Historical Data

The historical data trend for Tasly Pharmaceutical Group Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tasly Pharmaceutical Group Co Shiller PE Ratio Chart

Tasly Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.52 17.05 16.09 11.78 19.08

Tasly Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.52 16.01 15.95 19.08 18.10

Competitive Comparison of Tasly Pharmaceutical Group Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tasly Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tasly Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tasly Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tasly Pharmaceutical Group Co's Shiller PE Ratio falls into.



Tasly Pharmaceutical Group Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tasly Pharmaceutical Group Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=15.46/0.89
=17.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tasly Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Tasly Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.2/114.6694*114.6694
=0.200

Current CPI (Mar. 2024) = 114.6694.

Tasly Pharmaceutical Group Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.326 98.200 0.381
201409 0.271 98.900 0.314
201412 0.157 99.000 0.182
201503 0.228 99.900 0.262
201506 0.336 99.500 0.387
201509 0.257 100.500 0.293
201512 0.171 100.600 0.195
201603 0.183 102.200 0.205
201606 0.270 101.400 0.305
201609 0.207 102.400 0.232
201612 0.114 102.600 0.127
201703 0.210 103.200 0.233
201706 0.290 103.100 0.323
201709 0.350 104.100 0.386
201712 0.157 104.500 0.172
201803 0.246 105.300 0.268
201806 0.366 104.900 0.400
201809 0.290 106.600 0.312
201812 0.110 106.500 0.118
201903 0.297 107.700 0.316
201906 0.299 107.700 0.318
201909 0.150 109.800 0.157
201912 -0.090 111.200 -0.093
202003 0.196 112.300 0.200
202006 0.259 110.400 0.269
202009 0.270 111.700 0.277
202012 0.020 111.500 0.021
202103 0.215 112.662 0.219
202106 0.452 111.769 0.464
202109 0.323 112.215 0.330
202112 0.580 113.108 0.588
202203 -0.372 114.335 -0.373
202206 0.094 114.558 0.094
202209 0.048 115.339 0.048
202212 0.050 115.116 0.050
202303 0.180 115.116 0.179
202306 0.292 114.558 0.292
202309 0.219 115.339 0.218
202312 0.030 114.669 0.030
202403 0.200 114.669 0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tasly Pharmaceutical Group Co  (SHSE:600535) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Tasly Pharmaceutical Group Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tasly Pharmaceutical Group Co (SHSE:600535) Business Description

Traded in Other Exchanges
N/A
Address
2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.

Tasly Pharmaceutical Group Co (SHSE:600535) Headlines

No Headlines